CENTER FOR ADDICTION MEDICINE AT MGH

Since its formation in 2005, the Center has employed psychiatrists, neuroscientists, psychologists, neuropsychologists, and computer scientists who have conducted clinical and translational research that has resulted in new treatments for addictive disorders, extended the application of existing treatments, and reduced the stigma of addictive disorders... We have been among the first to test novel pharmacotherapies for addictive disorders, such as acetylcholinesterase inhibitors, dopamine D3 agonists, glycine antagonists and reuptake inhibitors, and cognitive-enhancing agents. We have also been among the first to test mindfulness training and real-time fMRI neurofeedback for addictive disorders. Our clinical trials established the knowledge base for the first clinical practice guidelines for nicotine dependence treatment for people with serious mental illness. Our scientists are working to understand the most effective components of 12-step facilitation groups such as Alcoholics..

Also known as: CAM

Primary location: Boston United States